Medicine Description apixatrack 2.5 mg
apixatrack 2.5 mg tablets is a medication belonging to the class of direct oral anticoagulants. Its primary mechanism of action involves the selective inhibition of Factor Xa, an essential protein in the coagulation cascade. By inhibiting Factor Xa, apixaban effectively reduces the conversion of prothrombin to thrombin, leading to decreased fibrin formation and ultimately preventing the development of blood clots. This targeted action helps diminish the risk of thromboembolic events, such as stroke and deep vein thrombosis, which are often associated with certain cardiovascular conditions.
Indications and Uses of apixatrack 2.5 mg tablets
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation
- Prevention of venous thromboembolism following hip or knee replacement surgery
- Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)
- Reduction of the risk of recurrence of DVT and PE
Side Effects of apixatrack 2.5 mg tablets
- Bleeding complications, including gastrointestinal and intracranial bleeding
- Skin reactions, such as rash or itching
- Hematoma formation
- Nausea
- Liver enzyme elevations
Storage and Handling
Store apixatrack 2.5 mg tablets at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.
Patient Advice and Precautions
Patients should be advised to inform healthcare providers of all medications they are taking, as apixaban can interact with various drugs. It is crucial to maintain consistency in the timing of doses. Patients should also be aware of signs of bleeding and seek medical attention if they experience unusual bruising, bleeding, or any other concerning symptoms.